Related Experiment Video
Updated: Aug 8, 2026
10:44
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
Published on: February 22, 2015
Remyelination in demyelinating disease
1MRC Cambridge Centre for Brain Repair, University of Cambridge, UK.
Bailliere'S Clinical Neurology
|April 2, 1999
Summary
Myelin repair in multiple sclerosis (MS) shows initial recovery but fails during disease progression. This chapter explores the biology of myelin repair and strategies for successful clinical translation in MS treatment.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Multiple sclerosis (MS) involves demyelination, where myelin sheaths are damaged.
- Partial remyelination occurs in MS lesions, aiding recovery from relapses.
- Remyelination failure contributes to progressive disability in MS.
Purpose of the Study:
- To explore the biological basis of myelin repair in central nervous system (CNS) demyelinating diseases.
- To investigate reasons for failed remyelination in multiple sclerosis.
- To discuss clinical translation of myelin repair therapies.
Main Methods:
- Review of experimental studies on CNS myelin repair.
- Analysis of biological mechanisms underlying remyelination.
- Discussion of clinical trial strategies and potential challenges.
Main Results:
- Experimental therapies demonstrate successful myelin repair in the CNS.
- Understanding of biological factors limiting remyelination in MS.
Conclusions:
- Therapeutic strategies for promoting myelin repair show promise for MS.
- Clinical translation requires careful consideration of potential risks and challenges.
- Further research is needed to overcome remyelination failure in progressive MS.
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...